Literature DB >> 34311776

Blood glucose promotes dengue virus infection in the mosquito Aedes aegypti.

Shih-Che Weng1, Po-Nien Tsao2,3, Shin-Hong Shiao4.   

Abstract

BACKGROUND: Dengue fever is the most rapidly spreading mosquito-borne viral disease globally. More than 2.5 billion people live in dengue-endemic areas. Previous studies suggested an interrelationship between diabetes mellitus (DM) and dengue hemorrhagic fever (DHF). Conversely, glycolysis is a critical metabolic pathway for optimal dengue virus (DENV) replication. However, little is known concerning the effect of glucose on DENV replication in mosquitoes. In this study, we investigated the impact of glucose on DENV replication in mosquitoes Aedes aegypti.
METHODS: Mosquitoes (Ae. aegypti UGAL/Rockefeller strain) were orally infected with DENV (serotype 2, 16681 strain) through infectious blood feeding. The DENV infection and transmission rates were determined by examining mosquito bodies and saliva, respectively, for DENV positivity at different time points after infection. In addition, a reverse genetic approach was applied by introducing double-stranded RNA against genes of interest into the mosquitoes to inhibit gene expression.
RESULTS: Our data revealed a significant increase of DENV genome levels in mosquitoes consuming an infectious blood meal supplemented with glucose, suggesting that blood glucose is an important factor for viral replication. Interestingly, a significant increase of DENV E protein levels was detected in the saliva 4 days faster in mosquitoes that consumed infectious blood meals supplemented with glucose than in those consuming infectious blood meals alone. Furthermore, we perform RNAi to silence AKT or TOR and investigate the molecular mechanism regulating the glucose-mediated enhancement of viral replication. Silencing of AKT or TOR significantly reduced DENV titers in mosquitoes.
CONCLUSIONS: This study suggested that blood glucose is beneficial to DENV replication and that it facilitates virus transmission in mosquitoes via AKT and TOR signaling. Therefore, our results strengthen our understanding of dengue fever and DM co-morbidity and possibly reveal new targets for specific antiviral therapies.
© 2021. The Author(s).

Entities:  

Keywords:  Aedes aegypti; Dengue virus; Glucose; Signaling pathway

Year:  2021        PMID: 34311776     DOI: 10.1186/s13071-021-04877-1

Source DB:  PubMed          Journal:  Parasit Vectors        ISSN: 1756-3305            Impact factor:   3.876


  52 in total

1.  Characteristics and Risk Factors for Fatality in Patients with Dengue Hemorrhagic Fever, Taiwan, 2014.

Authors:  Hsin-Yi Wei; Pei-Yun Shu; Min-Nan Hung
Journal:  Am J Trop Med Hyg       Date:  2016-06-06       Impact factor: 2.345

2.  Glycosylation, diabetes and dengue: effect on severity?

Authors:  Viroj Wiwanitkit
Journal:  Diabetes Metab Syndr       Date:  2012-03-18

3.  Dengue fever mortality score: A novel decision rule to predict death from dengue fever.

Authors:  Chien-Cheng Huang; Chien-Chin Hsu; How-Ran Guo; Shih-Bin Su; Hung-Jung Lin
Journal:  J Infect       Date:  2017-09-27       Impact factor: 6.072

4.  Infections in patients with diabetes mellitus: A review of pathogenesis.

Authors:  Juliana Casqueiro; Janine Casqueiro; Cresio Alves
Journal:  Indian J Endocrinol Metab       Date:  2012-03

Review 5.  Is diabetes a risk factor for a severe clinical presentation of dengue?--review and meta-analysis.

Authors:  Nan Shwe Nwe Htun; Peter Odermatt; Ikenna C Eze; Noémie Boillat-Blanco; Valérie D'Acremont; Nicole Probst-Hensch
Journal:  PLoS Negl Trop Dis       Date:  2015-04-24

6.  Incidence, Characteristics and Risk Factors of Acute Kidney Injury among Dengue Patients: A Retrospective Analysis.

Authors:  Tauqeer Hussain Mallhi; Amer Hayat Khan; Azreen Syazril Adnan; Azmi Sarriff; Yusra Habib Khan; Fauziah Jummaat
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

7.  Increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes' mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication.

Authors:  Ing-Kit Lee; Ching-Jung Hsieh; Rong-Fu Chen; Zih-Syuan Yang; Lin Wang; Chang-Mei Chen; Chiung-Fen Liu; Chung-Hao Huang; Chun-Yu Lin; Yen-Hsu Chen; Kuender D Yang; Jien-Wei Liu
Journal:  Biomed Res Int       Date:  2013-09-02       Impact factor: 3.411

Review 8.  Global Epidemiology of Dengue Outbreaks in 1990-2015: A Systematic Review and Meta-Analysis.

Authors:  Congcong Guo; Zixing Zhou; Zihao Wen; Yumei Liu; Chengli Zeng; Di Xiao; Meiling Ou; Yajing Han; Shiqi Huang; Dandan Liu; Xiaohong Ye; Xiaoqian Zou; Jing Wu; Huanyu Wang; Eddy Y Zeng; Chunxia Jing; Guang Yang
Journal:  Front Cell Infect Microbiol       Date:  2017-07-12       Impact factor: 5.293

9.  Metformin Use and Severe Dengue in Diabetic Adults.

Authors:  Htet Lin Htun; Tsin Wen Yeo; Clarence C Tam; Junxiong Pang; Yee Sin Leo; David C Lye
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

Review 10.  A Review: Aedes-Borne Arboviral Infections, Controls and Wolbachia-Based Strategies.

Authors:  Samson T Ogunlade; Michael T Meehan; Adeshina I Adekunle; Diana P Rojas; Oyelola A Adegboye; Emma S McBryde
Journal:  Vaccines (Basel)       Date:  2021-01-08
View more
  1 in total

1.  Aedes aegypti Shows Increased Susceptibility to Zika Virus via Both In Vitro and In Vivo Models of Type II Diabetes.

Authors:  Sasha R Azar; Rafael K Campos; Ruimei Yun; Taylor Strange; Shannan L Rossi; Kathryn A Hanley; Nikos Vasilakis; Scott C Weaver
Journal:  Viruses       Date:  2022-03-23       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.